These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21707481)

  • 1. Ceramide-based therapeutics for the treatment of cancer.
    Barth BM; Cabot MC; Kester M
    Anticancer Agents Med Chem; 2011 Nov; 11(9):911-9. PubMed ID: 21707481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceramide synthesis and metabolism as a target for cancer therapy.
    Reynolds CP; Maurer BJ; Kolesnick RN
    Cancer Lett; 2004 Apr; 206(2):169-80. PubMed ID: 15013522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The unfolding role of ceramide in coordinating retinoid-based cancer therapy.
    Ghandour B; Dbaibo G; Darwiche N
    Biochem J; 2021 Oct; 478(19):3621-3642. PubMed ID: 34648006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceramide: Therapeutic Potential in Combination Therapy for Cancer Treatment.
    Li F; Zhang N
    Curr Drug Metab; 2015; 17(1):37-51. PubMed ID: 26526831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery systems of ceramide in targeted cancer therapy: ceramide alone or in combination with other anti-tumor agents.
    Ma YY; Mou XZ; Ding YH; Zou H; Huang DS
    Expert Opin Drug Deliv; 2016 Oct; 13(10):1397-406. PubMed ID: 27168034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance.
    Liu YY; Hill RA; Li YT
    Adv Cancer Res; 2013; 117():59-89. PubMed ID: 23290777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Drug Transporter P-Glycoprotein and Its Impact on Ceramide Metabolism-An Unconventional Ally in Cancer Treatment.
    Ung J; Kassai M; Tan SF; Loughran TP; Feith DJ; Cabot MC
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting ceramide metabolism--a strategy for overcoming drug resistance.
    Senchenkov A; Litvak DA; Cabot MC
    J Natl Cancer Inst; 2001 Mar; 93(5):347-57. PubMed ID: 11238696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceramide glycosylation and related enzymes in cancer signaling and therapy.
    Li Z; Zhang L; Liu D; Wang C
    Biomed Pharmacother; 2021 Jul; 139():111565. PubMed ID: 33887691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
    Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
    Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancer.
    Morad SAF; Davis TS; MacDougall MR; Tan SF; Feith DJ; Desai DH; Amin SG; Kester M; Loughran TP; Cabot MC
    Biochem Pharmacol; 2017 Apr; 130():21-33. PubMed ID: 28189725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways.
    Hajj C; Becker-Flegler KA; Haimovitz-Friedman A
    Biol Chem; 2015 Jun; 396(6-7):669-79. PubMed ID: 25719313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the ceramide system in cancer.
    Henry B; Möller C; Dimanche-Boitrel MT; Gulbins E; Becker KA
    Cancer Lett; 2013 May; 332(2):286-94. PubMed ID: 21862212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Onus of Sphingolipid Enzymes in Cancer Drug Resistance.
    Morad SAF; Cabot MC
    Adv Cancer Res; 2018; 140():235-263. PubMed ID: 30060811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased ceramide production sensitizes breast cancer cell response to chemotherapy.
    Che J; Huang Y; Xu C; Zhang P
    Cancer Chemother Pharmacol; 2017 May; 79(5):933-941. PubMed ID: 28357533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles and therapeutic targeting of ceramide metabolism in cancer.
    Wajapeyee N; Beamon TC; Gupta R
    Mol Metab; 2024 May; 83():101936. PubMed ID: 38599378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingolipid targets in cancer therapy.
    Modrak DE; Gold DV; Goldenberg DM
    Mol Cancer Ther; 2006 Feb; 5(2):200-8. PubMed ID: 16505092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Codelivery of a Homoserine Derived Ceramide Analogue and Curcumin to Tumor Vasculature Inhibits Mouse Tumor Growth.
    Barui S; Saha S; Yakati V; Chaudhuri A
    Mol Pharm; 2016 Feb; 13(2):404-19. PubMed ID: 26716471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingolipid metabolism enzymes as targets for anticancer therapy.
    Kok JW; Sietsma H
    Curr Drug Targets; 2004 May; 5(4):375-82. PubMed ID: 15134220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of ceramide in cancer treatment.
    Moro K; Nagahashi M; Gabriel E; Takabe K; Wakai T
    Breast Cancer; 2019 Jul; 26(4):407-415. PubMed ID: 30963461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.